Literature DB >> 14532222

Assessment of immunoglobulin M enzyme immunoassays for diagnosis of measles.

Graham A Tipples1, Rasool Hamkar, Talat Mohktari-Azad, Michael Gray, Geoff Parkyn, Carol Head, Samuel Ratnam.   

Abstract

We evaluated the performance of three commercial measles immunoglobulin M enzyme immunoassays from Meddens, Denka Seiken, and Behring. The sensitivities were determined to be 96.7% for the Meddens and Denka Seiken assays and 87.9% for the Behring assay. The specificities of the assays were determined to be 94.6% for Meddens, 98.2% for Denka Seiken, and 98.7% for Behring.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532222      PMCID: PMC254325          DOI: 10.1128/JCM.41.10.4790-4792.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Nomenclature for describing the genetic characteristics of wild-type measles viruses (update).

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-08-17

2.  Nomenclature for describing the genetic characteristics of wild-type measles viruses (update). Part I.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-08-10

3.  Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset.

Authors:  R F Helfand; J L Heath; L J Anderson; E F Maes; D Guris; W J Bellini
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

4.  False-positive results of an enzyme immunoassay for rubella IgM in a case of measles.

Authors:  S M Donovan
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

5.  False positive rubeola IgM tests.

Authors:  S A Jenkerson; M Beller; J P Middaugh; D D Erdman
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

6.  Performance and reliability of the Enzygnost measles enzyme-linked immuno-sorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic.

Authors:  G Ozanne; M A d'Halewyn
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

7.  Human parvovirus B19 infections among exanthematic diseases notified as measles.

Authors:  R C Cubel; M M Siqueira; E O Santos; M F Pires; C M Cruz; J P Nascimento
Journal:  Rev Soc Bras Med Trop       Date:  1997 Jan-Feb       Impact factor: 1.581

8.  An enzyme-linked immunosorbent assay for the detection of IgG and IgM antibodies to human herpesvirus type 6.

Authors:  C A Parker; J M Weber
Journal:  J Virol Methods       Date:  1993-03       Impact factor: 2.014

9.  Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.

Authors:  S Ratnam; V Gadag; R West; J Burris; E Oates; F Stead; N Bouilianne
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Detection of IgM antibodies specific for measles virus by capture and indirect enzyme immunoassays.

Authors:  S Arista; D Ferraro; A Cascio; E Vizzi; R di Stefano
Journal:  Res Virol       Date:  1995 May-Jun
View more
  6 in total

1.  Acute Measles Encephalitis in an Immigrant Syrian Child: Case Report and Review of the Literature.

Authors:  Abdullah Al-Qayoudhi; Hanan Al-Kindi; Nabil Meki; Amal Al-Maani
Journal:  Oman Med J       Date:  2016-03

2.  Antibody Response to COVID-19 Virus - Heilongjiang Province and Gansu Province, China, 2020.

Authors:  Naiying Mao; Zhen Zhu; Shuangli Zhu; Deshan Yu; Jun Xu; Aili Cui; Lei Cao; Jinyuan Guo; Huiling Wang; Dongyan Wang; Dongmei Yan; Yang Song; Qian Yang; Zhongyi Jiang; Hui Zhang; Chang Shu; Ming Yang; Yanhai Wang; Jinbo Xiao; Zhenzhi Han; Yong Zhang; Yan Zhang; Wenbo Xu
Journal:  China CDC Wkly       Date:  2020-08-21

3.  The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.

Authors:  Shelly Bolotin; Gillian Lim; Vica Dang; Natasha Crowcroft; Jonathan Gubbay; Tony Mazzulli; Richard Schabas
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

4.  Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.

Authors:  Elisa V Gomez; Jessie L Bishop; Kimberley Jackson; Talia M Muram; Diane Phillips
Journal:  BioDrugs       Date:  2017-12       Impact factor: 5.807

5.  Sero-epidemiology and Risk Factor Analysis of Measles Among Children in Pakistan.

Authors:  Muhammad Hidayat Rasool; Ahsan Rafiq; Muhammad Zeeshan Nawaz; Muhammad Shafique; Muhammad Saqalein
Journal:  Pol J Microbiol       Date:  2018-06-30

6.  Improving measles incidence inference using age-structured serological data.

Authors:  Joaquin M Prada; C Jessica E Metcalf; Matthew J Ferrari
Journal:  Epidemiol Infect       Date:  2018-08-06       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.